Newswire

Landmark settlement could create new protections for harm reduction under disability law

A Christian group in Washington state on Tuesday announced a potentially landmark legal settlement that could establish new legal protections for harm reduction services for people experiencing drug addiction, including syringe exchange, under the Americans with Disabilities Act.

The ADA has previously been used to preserve access to addiction treatment, and in particular access to medications like methadone and buprenorphine. However, the settlement in Lewis County, Wash., sets a precedent in federal law that the ADA applies not just to treatment, but also to harm reduction services, which aim to help drug users preserve their health and reduce risk without demanding abstinence.

This development may significantly impact how harm reduction strategies are integrated into public health policies, potentially influencing funding and support for such initiatives across the country. As regulatory bodies and healthcare providers reassess their approaches, this ruling could lead to broader acceptance and implementation of harm reduction methods, ultimately improving health outcomes for vulnerable populations.

Explore deeper: the API & FDF Intelligence database is more than a directory. It combines global coverage of APIs, excipients, and finished dosage forms with real market intelligence. You’ll find: – Price ranges for APIs, excipients, and formulations. – DMF, CEP, and GMP compliance status. – Manufacturer portfolios by product and geography. – Direct contacts for every producer and FDF holder, ready for outreach. Instead of scattered spreadsheets and endless searches, the entire picture is a few clicks away. Subscription starts at an accessible rate — see how much time and budget you save by centralizing everything.
Start your 7-day trial and see what the database can do →